Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Genocea Biosciences (GNCA)

1.02 0.015 (1.49%)

02-22 16:00

Open:

1.01

Pre. Close:

1.005

High:

1.04

Low:

1

Volume:

905,793

Market Cap:

84M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.041 - 1.045

1.045 - 1.049

Low:

0.989 - 0.994

0.994 - 0.998

Close:

1.011 - 1.02

1.02 - 1.027

Technical analysis  (as of: 2018-02-22 5:01:20 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 1.26     One year: 1.47

Support:

Support1: 0.92    Support2: 0.82

Resistance:

Resistance1: 1.08    Resistance2: 1.26

Pivot:

0.97

Moving Averages:

MA(5):     MA(20): 0.96

MA(100): 1.16     MA(250): 3.72

MACD:

MACD(12,26):     Signal(12,26,9): -0.02

%K %D:

%K(14,3): 70.29     %D(3): 67.15

RSI:

RSI(14): 53.73

52-Week:

High: 7.29  Low: 0.791  Change(%): -77.8

Average Vol(K):

3-Month: 93979  10-Days 86198

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
GNCA has closed below upper band by 21.4%. Bollinger Bands are 84.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to GNCA's normal range. The bands have been in this narrow range for 88 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 12 Feb 2018 21:00:00 GMT
NEA Partner Ali Behbahani, MD Joins Genocea Biosciences' Board of Directors

Thu, 01 Feb 2018 21:57:25 GMT
Genocea Biosciences: 200% Dilution, Hopelessness And Anger. Why Am I Still ...

Thu, 15 Feb 2018 18:22:30 GMT
Genocea Biosciences' (GNCA) CEO Chip Clark on Q4 2017 Results - Earnings Call ...

Thu, 22 Feb 2018 16:41:15 GMT
What Do Wall Street Analysts Think Of Schlumberger Limited (SLB), Genocea ...

Fri, 23 Feb 2018 08:37:30 GMT
Genocea Biosciences (NASDAQ:GNCA) Upgraded to Buy by Needham & Company LLC

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

82.10

Shares Float (M)

81.93

% Held by Insiders

% Held by Institutions

59.20

Shares Short (K)

2871

Shares Short Prior Month (K)

3120

Stock Financials

EPS

-1.980

EPS Est. Current Year

-1.920

EPS Est. Next Year

-1.110

EPS Est. Next Quarter

-0.370

Forward EPS

-0.658

Book Value (p.s.)

22.270

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-122.6

Return on Equity (ttm)

-259.7

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.655

Qtrly Earnings Growth

Operating Cash Flow (M)

Levered Free Cash Flow (M)

atoplab.com

Valuation

P/E

-0.52

P/E Growth Ratio

0.01

P/BV

0.05

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.